Magnus Sjogren

Associate Professor, Chief Medical Officer of DiaGenic ASA
DiaGenic ASA, Oslo

Fields of interest

Tauopathies, aging process, Alzheimer’s disease, Parkinson’s disease.


Recent publications

Olsson S, Jood K, Melander O, Sjögren M, Norrving B, Nilsson M, Lindgren A, Jern C.:
Lack of association between genetic variations in the KALRN region and ischemic stroke.
Clin Biochem., 2011, 44(12):1018-20

Olsson S, Melander O, Jood K, Smith JG, Lövkvist H, Sjögren M, Engström G, Norrving B, Lindgren A, Jern C.:
Genetic variant on chromosome 12p13 does not show association to ischemic stroke in 3 Swedish case-control studies.
Stroke., 2011, 42(1):214-6

Sacuiu S, Gustafson D, Sjögren M, Guo X, Ostling S, Johansson B, Skoog I.:
Secular changes in cognitive predictors of dementia and mortality in 70-year-olds.
Neurology., 2010, 75(9):779-85

Jonsson M, Edman A, Lind K, Rolstad S, Sjögren M, Wallin A.:
Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia.
Int J Geriatr Psychiatry., 2010, 25(6):588-95

Slats D, Spies PE, Sjögren MJ, Verhey FR, Verbeek MM, Olde Rikkert MG.:
Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports.
Case Rep Neurol., 2010, 2(1):5-11

Sacuiu S, Gustafson D, Johansson B, Thorvaldsson V, Berg S, Sjögren M, Guo X, Ostling S, Skoog I.:
The pattern of cognitive symptoms predicts time to dementia onset.
Alzheimers Dement., 2009, 5(3):199-206

Sihlbom C, Davidsson P, Sjögren M, Wahlund LO, Nilsson CL.:
Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer’s disease patients and healthy individuals.
Neurochem Res., 2008, 33(7):1332-40

Björkdahl C, Sjögren MJ, Zhou X, Concha H, Avila J, Winblad B, Pei JJ.:
Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.
J Neurosci Res., 2008, 86(6):1343-52

Federsel HJ, Hedberg M, Qvarnström FR, Sjögren MP, Tian W.:
Construction of a chiral central nervous system (CNS)-active aminotetralin drug compound based on a synthesis strategy using multitasking properties of (S)-1-phenylethylamine.
Acc Chem Res., 2007, 40(12):1377-84

Zhou XW, Li X, Bjorkdahl C, Sjogren MJ, Alafuzoff I, Soininen H, Grundke-Iqbal I, Iqbal K, Winblad B, Pei JJ.:
Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer’s brains.
Neurobiol Dis., 2006, 22(3):657-68